Anaemia in acute HIV-1 subtype C infection

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Mlisana, Koleka ^a   Auld, Sara C ^a,b   Grobler, Anneke ^a   van Loggerenberg, Francois ^a   Williamson, Carolyn ^c   Iriogbe, Itua ^a   Sobieszczyk, Magdalena E ^b   Abdool Karim, Salim S ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; SEROCONVERSION; SOUTH AFRICA; ACUTE DISEASE; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; TIME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACUTE DISEASE; ANEMIA; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; SOUTH AFRICA; TIME FACTORS;

EID: 45449095706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001626     Document Type: Article

References (19)

1. Kreuzer KA, Rockstroh JK (1997) Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 75: 179-87.
2. Savarino A, Pescarmona GP, Boelaert JR (1999) Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 17: 279-287.
3. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, et al. (2005) Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. J Acquit Immune Defic Syndr 39(5): 620-625.
4. Moore R (1999) Human immunodeficiency virus infection, anemia, and survival. Clin Inf Dis 29: 44-49.
5. Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, et al. (2002) Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Inf Dis 34: 260-66.
6. Lundgren JD, Mocroft A (2003) Anemia and survival in human immunodeficiency virus. Clin Inf Dis 37(Suppl 4): S297-303.
7. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, et al. (1999) Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS 13: 943-950.
8. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW (1998) Epidemiology of anemia in human immunodeficiency virus (HIV-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 91(1): 301-308.
9. Zhou J, Kumarasamy N, TREAT Asia HIV Observational Database (2005) Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD). HIV Medicine 6: 216-223.
10. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, et al. (2005) Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 40(2): 219-225.
11. WHO (1992) The Prevalence of Anaemia in Women: A Tabulation of Available Information in Document WHO/MCH/MSM/92.2. Geneva: World Health Organization.
12. Bahner I, Keams K, Coutinho S, Leonard EH, Kohn DB (1997) Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1 induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 90(5): 1787-98.
13. Kreuzer KA, Rockstroh JK, Jelkmann W, Theisen A, Spengler U, et al. (1997) Inadequate erythropoletin response to anaemia in HIV patients: relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors. British J Hematol 96. 235-239.
14. Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, et al. (1996) Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87(3): 919-925.
15. Moses A, Nelson J, Bagby GC Jr (1998) The influence of human immunodeficiency virus-1 on hematopoeisis. Blood 91(5): 1479-95.
16. Deschamps M, Fitzgerald DW, Pape JW, Johnson WD Jr (2000) HIV infection in Haiti: nataral history and disease progression. AIDS 14(16): 2515-2521.
17. Lawn SD, Butera ST, Folks TM (2001) Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Reviews 14(4): 753-777.
18. Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, et al. (2004) Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 37(2): 1245-52.
19. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW (2005) The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 165: 2229-2236.